A multicenter observational retrospective study of second-line treatment with daratumumab-bortezomib-dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomide
一项多中心回顾性观察研究,评估达雷妥尤单抗-硼替佐米-地塞米松(DaraVd)二线治疗对来那度胺耐药的多发性骨髓瘤患者的疗效。
期刊:Clinical and Experimental Medicine
影响因子:3.5
doi:10.1007/s10238-025-01956-w
Rizzello, I; Sacchetti, I; Barbato, S; Solli, V; Stefanoni, P; Cani, L; Quaresima, M; Belotti, A; Sgherza, N; Gentile, M; Zambello, R; Barilà, G; Celli, M; Mele, G; Mancuso, K; Pantani, L; Tacchetti, P; Talarico, M; Puppi, M; Manzato, E; Restuccia, R; Masci, S; Ghibellini, S; Bigi, F; Cavo, M; Zamagni, E